Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972062 · ClinicalTrials.gov registry record · NA
Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis
A NA study, sponsored by University of North Carolina, Charlotte.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00972062: Completed NA study, sponsored by University of North Carolina, Charlotte.
NCT00972062 is a NA study that has completed, run by University of North Carolina, Charlotte. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00972062, a NA study, has completed, sponsored by University of North Carolina, Charlotte.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as their subcutaneous medication for managing their multiple sclerosis. Injection site reactions have been indicated as one of the major reasons for discontinuing treatment with the subcutaneous medications (Betaseron, Copaxone, and Rebif) for multiple sclerosis.
Interventions
- OTHER Placebo Cream
- OTHER Bach's Rescue Remedy Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00972062 record still lists
NCT00972062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Cream is the first listed.
NCT00972062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00972062 about?
NCT00972062 is a clinical study titled "Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis". The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as their subcutaneous medication for managing their multiple sclerosis. Injection site reactions have b...
What is the current status of trial NCT00972062?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-06. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00972062?
The interventions under investigation include: Placebo Cream (OTHER), Bach's Rescue Remedy Cream (OTHER).
Who is sponsoring clinical trial NCT00972062?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00972062's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia